Skip to content

Study on the treatment of refractory peripheral facial paralysis by acupuncture based on multi - modal fMRI

Study on the treatment of refractory peripheral facial paralysis by acupuncture based on multi - modal fMRI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011232
Enrollment
Unknown
Registered
2017-04-24
Start date
2017-05-01
Completion date
Unknown
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory peripheral facial paralysis

Interventions

Chinese medicine combined with acupuncture group :Chinese medicine combined with acupuncture

Sponsors

First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) diagnosed as facial nerve palsy according to Western diagnostic criteria; (2) disease classification criteria HBS II to grade IV, the incidence of more than 3 months; (3) between 18-60 years old, male or female; (4) the recent test (within 3 months) no persistent severe pain, non-menstrual period of women, pregnancy test negative; (5) no congenital or genetic disease, endocrine immune disease, mental or neurological diseases and severe heart, liver, kidney disease; (6) no history of mental or neurological medication; (7) meet the requirements of magnetic resonance imaging (no pacemaker, stent, metal dentures and no claustrophobia, etc.); (8) right hand; (9) routine MRI scan intracranial no obvious abnormalities; (10) voluntarily signed experimental informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with non-peripheral facial paralysis; (2) peripheral facial paralysis in patients with duration of less than 3 months or have not been related to treatment; (3) a history of mental or neurological disease; (4) a history of mental or neurological medication; (5) have cardiovascular, liver, kidney, hematopoietic system and other primary diseases; (6) women's menstrual period, pregnant or lactating women and allergies; (7) MRI test contraindications (cardiac pacemaker, claustrophobia, etc.); (8) non-right hand; (9) can not cooperate with the experiment (such as refusing to sign informed consent and can not adhere to the whole experiment); (10) MRI pain in the presence of pain.

Design outcomes

Primary

MeasureTime frame
fMRI;

Contacts

Public ContactAihong Yuan

First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

490603279@qq.com+86 15395001068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026